Andromeda Metals (ADN) Q3 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 TU earnings summary
29 Apr, 2026Executive summary
Advanced Early Works at the Great White Project, de-risking construction and reducing required equity for final investment decision on Stage 1A+.
Progressed cornerstone equity funding with a Middle East-based investor, though process delayed by regional geopolitical events.
Implemented cost-saving measures totaling approximately $3 million across Early Works, procurement, and administrative costs.
Completed key milestones for the High Purity Alumina (HPA) Project, including pilot plant equipment assembly and initial feedstock analysis.
Financial highlights
Cash and cash equivalents at quarter-end were $5.2 million, down from $10.1 million in the previous quarter.
Net cash used in operating activities was $1.76 million for the quarter.
Net cash used in investing activities was $3.05 million, primarily for property, plant, equipment, and exploration.
Net cash used in financing activities was $49,000.
R&D tax refund of approximately $1.6 million expected, based on $3.4 million eligible expenditure.
Outlook and guidance
Funding process for Stage 1A+ of the Great White Project remains ongoing, with alternative pathways being assessed due to geopolitical delays.
HPA pilot plant commissioning and first production of commercial samples planned for Q2 2026.
Company expects to continue operations and meet objectives, supported by cost savings and anticipated tax refund.
Latest events from Andromeda Metals
- Construction-ready kaolin project advances with secured offtakes and narrowed net loss.ADN
H2 202426 Mar 2026 - Significant impairment and funding needs led to a $101.6 million net loss despite capital raised.ADN
H1 202620 Mar 2026 - Shovel-ready kaolin project advances with strong economics, secured offtakes, and active funding efforts.ADN
Investor Update20 Jan 2026 - AGM confirmed strong project economics, secured offtakes, and advancing funding and development.ADN
AGM 202520 Nov 2025 - Advancing two high-value mineral projects with secured funding, offtakes, and strong market outlook.ADN
Noosa Mining Investor Conference18 Nov 2025 - Secured major funding, advanced HPA project, and raised $13M to support ongoing development.ADN
Q1 2026 TU30 Oct 2025 - Advancing a de-risked kaolin project and innovative HPA venture with robust market outlook.ADN
Investor Presentation16 Oct 2025 - Net loss narrowed 45% as funding and offtake deals advanced the Great White Project.ADN
H1 20257 Oct 2025 - GWP advanced with secured offtakes, improved loss, and strong HPA project economics.ADN
H2 20255 Oct 2025